GlassScriptPhysician profile
Mir T Ali
NPI 1275559072
$4,932.90
in general payments reported to CMS, 2019-2025
42 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $244 · 2021: $939 · 2022: $1,431 · 2023: $452 · 2024: $516 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Education: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.88 |
| Education | $252.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $655.50 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $529.47 | 2019-2025 | |
| Glaxosmithkline, LLC. | $483.71 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.56 | 2019-2022 | |
| Axsome Therapeutics, INC. | $214.48 | 2023-2025 | Sunosi |
| Mallinckrodt Hospital Products INC. | $178.90 | 2020-2022 | |
| Abbott Laboratories | $170.30 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $168.45 | 2021-2023 | Dupixent |
| Mylan Specialty L.P. | $162.83 | 2020-2022 | |
| Genentech USA, INC. | $147.08 | 2019-2022 | |
| Inspire Medical Systems, INC. | $126.96 | 2023-2025 | Inspire |
| Resmed Corp | $126.93 | 2019-2023 | |
| Avadel Cns Pharmaceuticals, LLC | $122.90 | 2024-2025 | Lumryz |
| Genzyme Corporation | $121.25 | 2019-2023 | |
| Baxter Healthcare | $120.28 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mir Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.